Cilostazol
Generic Details
Generic Name
Cilostazol
Other Names
- Pletal
Drug Class
- Phosphodiesterase Inhibitor
Chemical Formula
C20H27N5O2
Molecular Weight
369.46 g/mol
Mechanism of Action
- Cilostazol inhibits platelet aggregation and reduces smooth muscle cell proliferation.
Indications
- Intermittent claudication (pain in the legs while walking due to decreased blood flow)
Common Dosage Forms
- Tablet
Typical Dosage
- 100 mg twice daily at least 30 minutes before or 2 hours after breakfast and dinner
Pediatric Dosage
- Not established
Geriatric Dosage
- Initiate therapy at the lower end of the adult dosing range
Side Effects
- Headache
- Diarrhea
- Abnormal stools
- Abdominal pain
- Dizziness
Contraindications
- History of heart failure
- Severe hepatic dysfunction
- Hypersensitivity to cilostazol or other related drugs
Pregnancy Category
- C - Use with caution
Lactation Safety
- Not recommended
Drug Interactions
- Strong CYP3A4 inhibitors may increase cilostazol levels
- Strong CYP3A4 inducers may decrease cilostazol levels
Overdose Symptoms
- Severe headache
- Diarrhea
- Tachycardia
Antidote for Overdose
- There is no specific antidote, treatment should be symptomatic and supportive
Storage Conditions
- Store at room temperature between 20-25°C (68-77°F)
Pharmacokinetics
- Absorption: Rapid and almost complete
- Distribution: Protein binding is approximately 95%
- Metabolism: Primarily hepatic via CYP3A4 and CYP2C19
- Excretion: Mainly through urine (74%) and feces (20%)
Precautions
- Use with caution in patients with bleeding disorders
- Monitor for signs of heart failure exacerbation
Warnings
- Increased risk of myocardial infarction and cardiovascular death in patients with heart failure